Bruker CORP Schedule 13G passive stakes

FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, disclosing a beneficial ownership of 15.0% of Bruker Corp's common stock as of June 30, 2026.

Several investment management firms have collectively disclosed beneficial ownership of approximately 11.8% of Bruker Corp's common stock as of March 31, 2026.

FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 12.4% in Bruker Corp's common stock as of March 31, 2026.

The Vanguard Group filed an amended Schedule 13G for Bruker Corp, reporting zero beneficial ownership following an internal realignment.

Orbis Investment Management and its affiliates have disclosed a combined beneficial ownership of 10.6% of Bruker Corp's common stock.

Orbis Investment Management Ltd, Allan Gray Australia Pty Ltd, and Orbis Investment Management (U.S.) L.P. collectively reported beneficial ownership of 9.8% of Bruker Corp's common stock.

Orbis Investment Management and its affiliates have reported a collective beneficial ownership of 9.3% of Bruker Corp's common stock as of September 30, 2025.

T. Rowe Price Investment Management, Inc. has filed an amendment to its Schedule 13G, reporting a 5.1% beneficial ownership stake in Bruker Corp. common stock.

FMR LLC and Abigail P. Johnson have disclosed beneficial ownership of 11.0% of Bruker Corp's common stock as of September 30, 2025.

T. Rowe Price Investment Management, Inc. reported a 7.5% beneficial ownership stake in Bruker Corp, holding 11,430,636 shares of common stock.

FMR LLC and Abigail P. Johnson have reported a passive 5.5% beneficial ownership stake in Bruker Corp as of June 30, 2025.

FMR LLC and its Chairman and CEO, Abigail P. Johnson, have filed an amended Schedule 13G, reporting a combined beneficial ownership of 7.0% in Bruker Corp's common stock as of March 31, 2025.